Narkotikapolitiska notiser och nyheter

I en undersökning genomförd 2025* uppgav lite mer än var fjärde person i Sverige (18–83 år) att de under det senaste året haft någon i sin närhet som de anser dricker för mycket.

Det finns ett stigma, båda kring att själv ha alkoholproblem och att ha en närstående med alkoholproblem, som kan göra att man varken pratar om det eller söker hjälp.

Yet decades of Federal drug control policy have neglected marijuana’s medical uses. That oversight has limited the ability of scientists and manufacturers to complete the necessary research on safety and efficacy to inform doctors and patients.

Marijuana is currently controlled under Schedule I of the Controlled Substances Act (CSA). In 2023, the Department of Health and Human Services (HHS) recommended to the Drug Enforcement Agency that marijuana be controlled under Schedule III of the CSA. Schedule I drugs are defined as drugs with no currently accepted medical use, a high potential for abuse, and a lack of accepted safety for use of the drug under medical supervision. Schedule III drugs are classified as having a potential for abuse less than the drugs or other substances in Schedules I and II, a currently accepted medical use in treatment in the United States, and a potential for moderate or low physical dependence or high psychological dependence in the event of drug abuse.